Location History:
- Montvale, NY (US) (2013)
- Montvale, NJ (US) (2008 - 2014)
- Natick, MA (US) (2011 - 2020)
Company Filing History:
12 out of 40 
10 out of 130 
1 out of 2 Years Active: 2008-2020
Title: Jianguo Ma: Innovator in Central Nervous System Treatments
Introduction
Jianguo Ma is a prolific inventor based in Natick, MA, known for his significant contributions to the field of central nervous system (CNS) therapies. With an impressive portfolio of 23 patents, his work focuses on developing innovative treatments for various CNS disorders, making a profound impact in the pharmaceutical industry.
Latest Patents
Among Jianguo Ma's latest innovations is his groundbreaking work on cycloalkylamines as monoamine reuptake inhibitors. This invention relates to novel cyclohexylamine derivatives designed for the treatment and prevention of CNS disorders, including depression, anxiety, schizophrenia, and sleep disorders. It outlines methods for the synthesis of these compounds, which also includes pharmaceutical compositions featuring the new derivatives. The invention further elaborates on techniques to inhibit the reuptake of essential monoamines, such as dopamine, serotonin, and norepinephrine, from the synaptic cleft, ultimately aiming to modulate one or more monoamine transporters for therapeutic benefits.
Career Highlights
Jianguo Ma has worked at notable pharmaceutical companies such as Memory Pharmaceuticals Corporation and Sunovion Pharmaceuticals Inc. His experience at these organizations has allowed him to leverage his inventive capabilities to advance drug development processes, particularly in the realm of psychiatry and neuropharmacology.
Collaborations
Throughout his career, Jianguo has collaborated with esteemed colleagues, including Wenge Xie and Brian Herbert. These professional relationships have fostered an environment of innovation and scientific inquiry, enhancing the development of effective therapeutic solutions.
Conclusion
In summary, Jianguo Ma stands out as a significant figure in the field of CNS disorder treatment. His extensive patent portfolio and collaborations with leading pharmaceutical companies underscore his dedication to improving mental health through innovative inventions. Ma's work continues to pave the way for advancements in the understanding and treatment of complex neurological conditions, marking him as a vital contributor to contemporary medicine.